International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder | Zendy

Cleo L. Crunelle | Zendy; Wim van den Brink | Zendy; Franz Moggi | Zendy; Maija Konstenius | Zendy; Johan Franck | Zendy; Frances R. Levin | Zendy; Geurt van de Glind | Zendy; Zsolt Demetrovics | Zendy; Corné Coetzee | Zendy; Mathias Luderer | Zendy; Arnt Schellekens | Zendy; Frieda Matthys | Zendy

Open Access

International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder

Author(s) -

Cleo L. Crunelle,

Wim van den Brink,

Franz Moggi,

Maija Konstenius,

Johan Franck,

Frances R. Levin,

Geurt van de Glind,

Zsolt Demetrovics,

Corné Coetzee,

Mathias Luderer,

Arnt Schellekens,

Frieda Matthys

Publication year - 2018

Publication title -

european addiction research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.862

H-Index - 54

eISSN - 1421-9891

pISSN - 1022-6877

DOI - 10.1159/000487767

Subject(s) - methylphenidate , atomoxetine , attention deficit hyperactivity disorder , comorbidity , psychiatry , substance abuse , attention deficit , conduct disorder , medicine , psychology , clinical psychology

Adult attention deficit/hyperactivity disorder (ADHD) often co-occurs with substance use disorders (SUD) and is associated with early onset and more severe development of SUD and with reduced treatment effectiveness. Screening tools allow for a good recognition of possible ADHD in adults with SUD and should be used routinely, followed by an ADHD diagnostic process initiated as soon as possible. Simultaneous and integrated treatment of ADHD and SUD, using a combination of pharmaco- and psychotherapy, is recommended. Long-acting methylphenidate, extended-release amphetamines, and atomoxetine with up-titration to higher dosages may be considered in patients unresponsive to standard doses. This paper includes evidence- and consensus-based recommendations developed to provide guidance in the screening, diagnosis and treatment of patients with ADHD-SUD comorbidity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research